In their ongoing quest to develop the latest and most effective drugs for disease treatment, pharmaceutical researchers are looking deep— as in, deep underground.
A new method to identify previously hidden details about the structures of proteins may speed the process of novel drug design, according to scientists at Rice University. How could this work affect pharmaceutical companies that design drugs? Find out...
In this webinar we introduce NanoBRET™ using a donor/accpetor combination consisting of NanoLuc™ luciferase and Halotag® labeling technology.
Immunocore Limited announced that its most advanced ImmTAC drug, IMCgp100 for the treatment of late stage melanoma, has reached Maximum Tolerated Dose (MTD) and the dose escalation part of this phase 1 clinical study has been completed. How are melanoma cancer cells killed by T cells when activated by the drug? Watch now...
Earlier this month, MPI Research broke ground for a new preclinical imaging center, which will open in spring 2014 in Mattawan, Mich. How will this new facility help advance drug development? Scott Haller, director of the new molecular imaging center, explains.
A recent study by a University of Missouri researcher shows that resveratrol, a compound found in grape skins and red wine, can make certain tumor cells more susceptible to radiation treatment. Can researchers develop a successful method to deliver the compound to tumor sites to treat many cancers?
At a recent forum in the UK, researchers explained how microneedle technology could revolutionize the way drugs are delivered– from small molecules to vaccines and biological compounds.
Kaiser Permanente Northern California nearly doubled the rate of blood pressure control among adult members with diagnosed hypertension through one of the largest, community-based hypertension programs in the nation. The program encouraged single-pill combination therapy— combining multiple drugs into one pill.
Researchers have provided the first comprehensive compendium of mutational processes that drive tumor development. Together, these mutational processes explain most mutations found in 30 of the most common cancer types. This new understanding of cancer development could help to treat and prevent a wide range of cancers.
Simultaneous, Formalin-Free Preservation of Tissue Biomarkers and Morphology for Biomarker Discovery and BiobankingJune 17, 2013 11:47 am Webinars Comments
In this webinar, PreAnalytix will introduce a new technology, the PAXgene Tissue System, which preserves tissue morphology, DNA, RNA, miRNA, proteins, and phosphoproteins in the same sample without cross-linking of biomolecules or damage to the tissue architecture or histomorphology.
Abacalab’s Protocol Labacus App for iPad, Android tablet or laptop that helps technicians, scientists, clinicians, and others working on the move. The Protocol Labacus provides an overview of the steps in a procedure and detailed instructions for each step.
The Perfecta3D Hanging Drop Plates from 3D Biomatrix help researchers focused on cancer research and drug development, toxicology testing, and stem cell research to grow cells in small spherical 3D clusters.
Taking a sample from just one part of a tumor may not give a full picture of its genetic landscape, according to a study by Cancer Research UK scientists.
This webinar discusses the methodologies used to characterize sub-visible particulates in parenterals, Dynamic Image Analysis for particulate characterization and orthogonal instrument methodologies.
This webinar highlights the utility of these mouse models in antibody engineering, hematopoiesis, autoimmune diseases, and oncology research.
The importance of signaling on cellular drug activity, along with a case study comparing biochemical activities and cellular activities of clinical kinase inhibitors are reviewed in this free webcast.